Idéal Investisseur
Français English
CAC 40 : Market open
8 194,90 pts
-0.10%


Last updated : 10/06/2026 - 11h07
🏠 Home   ➤    Stock news

DBV TECHNOLOGIES Stock: Shares Fall 11.11% Over the Week

DBV Technologies' stock closed at €3.20 on Friday, marking a weekly decline of 11.11%. This underperformance comes in a context where the CAC 40 limited its losses to 0.59% and the SBF 120 to 0.43% over the same period. Despite this setback, the stock maintains an impressive annual performance of 399.2%.


DBV TECHNOLOGIES Stock: Shares Fall 11.11% Over the Week

Weekly Stock Performance

Over the past week, DBV Technologies' stock price followed a downward trajectory, closing at €3.20 on Friday after a session up by 2.24%. This negative weekly change of 11.11% contrasts with the robustness shown over the year, where the stock has increased by 399.2%, driven by a sustained upward momentum since the beginning of 2025. Trading was particularly lively, with notable volumes observed towards the end of the week. On December 23, the price dropped by 8.61% to €3.13, while December 22 recorded a decrease of 4.86% to €3.425. This weekly volatility, with a monthly volatility of 34.52%, highlights an increased sensitivity to market movements. For comparison, the CAC 40 only fell by 0.59% and the SBF 120 by 0.43% over the same period, indicating that DBV Technologies underperformed the major French indices. The beta of 0.36 measures a lower correlation with the overall market, which did not prevent a more marked decline this week. The support threshold is at €2.26 and resistance at €3.68, thus framing recent fluctuations. This weekly development opposes the positive monthly trend of over 40%, but highlights a rotation of capital with volumes increasing during bearish sessions. The high float at nearly 99% facilitates these movements, while the market capitalization hovers around 500 million euros according to recent sources. Overall, this week of correction comes after a series of previous increases, such as +108% over three months and +113% over six months, confirming the strong annual momentum despite the brief setback.

Institutional Movements

Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
Before 9 AM every morning Euronext data AI-powered analysis

The Caisse des dépôts et consignations (CDC) crossed below the 5% threshold of capital and voting rights of DBV Technologies on December 17, according to a declaration to the AMF. This move below 5% reflects an adjustment in the public institution's holdings, occurring during a week of declining stock prices for the company. Daily trading shows a continuation of selling pressure: after stability at €3.68 on December 18, the price declined by 2.17% on December 19 to €3.60, before more pronounced drops towards the end of the week. This institutional context coincides with the weekly close at €3.20, in a Christmas market characterized by variable but sustained volumes.

Technical Analysis

From a technical standpoint, the stock is trading above its 50-day moving average at €2.70 and well above the 200-day moving average at €1.90, indicating a bullish medium-term position. The RSI at 66 reflects a neutral to positive dynamic, without imminent overbuying. The MACD line at 0.24 confirms a bullish signal, while the Bollinger Bands stretch from €1.91 at the bottom to €3.96 at the top, enveloping the current price in a zone of moderate volatility. The resistance threshold at €3.68 remains close, while the support at €2.26 provides a distant floor.



Sector Santé · Biotechnologies · Vaccins et laboratoires de recherche Biotechnologie


Free · every morning · before 9am
Never miss a move on your stocks
The trend behind the prices · Euronext

Contexte

Period
  • Period: 1T2026
Key reported figures
  • Revenue: 1M€dedollars
  • Net income: -47,6M€dedollars
  • Free cash flow: -49M€dedollars
Guidance from the release
  • Toute l'équipe de DBV démontre une focalisation et une rigueur exceptionnelles alors que nous abordons des étapes décisives au cours des prochains mois.
Risks mentioned
  • Augmentation significative des dépenses de R&D.
  • Perte nette en hausse à 47,6 millions de dollars.
Opportunities identified
  • Dépôt de la demande de licence biologique prévu pour 2026.

Les informations présentées dans cet article sont fournies à titre purement indicatif et ne constituent en aucun cas une recommandation d'investissement, une incitation à acheter ou vendre un actif financier, ni un conseil en placement. Le lecteur est invité à réaliser ses propres recherches avant toute décision.

Les investissements en bourse comportent des risques, notamment de perte en capital. La performance passée d'un actif ou d'un marché ne présage en rien de ses performances futures. Toute décision d'investissement doit être prise en tenant compte de votre situation financière personnelle, de vos objectifs et de votre tolérance au risque.

Annonce
Chaque matin
Les signaux techniques du marché,
avant l'ouverture.
CAC 40 · SBF 120 · Signaux · Analystes
🤖
Édition du jour — avant bourse
CAC 40
7 702
-0,87%
SBF 120
5 827
-0,87%
📈 Signaux haussiers
+5,2%
+1,8%
+0,9%
📉 Signaux baissiers
-14%
-5,7%
🔄 Avis analystes
▲ 35 €
▼ 80 €
Inscrivez-vous pour tout voir →
Avant 9h chaque matin
Données Euronext
Analyse automatique IA





BOURSE · Chaque matin
La synthèse bourse,
avant l'ouverture.
Notre moteur analyse chaque nuit le CAC 40 et le SBF 120. Ce qui mérite attention remonte directement dans votre boîte mail. Gratuit.
Avant 9h00 1000+ inscrits 100% gratuit
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours sur les valeurs Euronext, chaque matin avant 9h.
tendance · 6 séances
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours